Toxoplasma gondii and anxiety disorders in a community-based sample

Brain, Behavior, and Immunity

Volumn 43, Issue , 2015, Pages 192-197

  Markovitz, Adam A ^a   Simanek, Amanda M ^b   Yolken, Robert H ^c   Galea, Sandro ^d   Koenen, Karestan C ^d   Chen, Shu ^a   Aiello, Allison E ^e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Columbia University Mailman School of Public Health ^*  (United States)

^e IL   (United States)

Author keywords

Depression; Generalized anxiety disorder; Infection; Mental health; PTSD; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MOOD DISORDER; POPULATION RESEARCH; POSTTRAUMATIC STRESS DISORDER; TOXOPLASMA GONDII; TOXOPLASMOSIS; AGED; ANXIETY DISORDERS; COMPLICATION; DEPRESSIVE DISORDER; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TOXOPLASMA;

ADULT; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84919390920     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.08.001     Document Type: Article

References (49)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, D.C. 4th ed.
2. Arling T.A., Yolken R.H., Lapidus M., Langenberg P., Dickerson F.B., Zimmerman S.A., Balis T., Cabassa J.A., Scrandis D.A., Tonelli L.H., Postolache T.T. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 2009, 197:905-908.
3. Benros M.E., Waltoft B.L., Nordentoft M., Ostergaard S.D., Eaton W.W., Krogh J., Mortensen P.B. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 2013, 70:812-820.
4. Berdoy M., Webster J.P., Macdonald D.W. Parasite-altered behaviour: is the effect of Toxoplasma gondii on Rattus norvegicus specific?. Parasitology 1995, 111(Pt. 4):403-409.
5. Berdoy M., Webster J.P., Macdonald D.W. Fatal attraction in rats infected with Toxoplasma gondii. Proc. Biol. Sci. 2000, 267:1591-1594.
6. Berenreiterova M., Flegr J., Kubena A.A., Nemec P. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 2011, 6:e28925.
7. Carruthers V.B., Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr. Bull. 2007, 33:745-751.
8. Centers for Disease Control and Prevention, 2009. Center for Disease Control and Prevention Ambulatory Care Drug Database System.
9. Cetinkaya Z., Yazar S., Gecici O., Namli M.N. Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophr. Bull. 2007, 33:789-791.
10. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 1994, 47:1245-1251.
11. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
12. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165:59-65.
13. de la Mora M.P., Gallegos-Cari A., Arizmendi-Garcia Y., Marcellino D., Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog. Neurobiol. 2010, 90:198-216.
14. Etkin A., Prater K.E., Schatzberg A.F., Menon V., Greicius M.D. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch. Gen. Psychiatry 2009, 66:1361-1372.
15. Fekadu A., Shibre T., Cleare A.J. Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms. Folia Parasitol. (Praha) 2010, 57:105-113.
16. Groer M.W., Yolken R.H., Xiao J.C., Beckstead J.W., Fuchs D., Mohapatra S.S., Seyfang A., Postolache T.T. Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am. J. Obstet. Gynecol. 2011, 204(433):e431-437.
17. Hamer D. Genetics. Rethinking behavior genetics. Science 2002, 298:71-72.
18. Hamidinejat H., Ghorbanpoor M., Hosseini H., Alavi S.M., Nabavi L., Jalali M.H., Borojeni M.P., Jafari H., Mohammadaligol S. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int. J. Infect. Dis. 2010, 14:e978-981.
19. Haroon F., Handel U., Angenstein F., Goldschmidt J., Kreutzmann P., Lison H., Fischer K.D., Scheich H., Wetzel W., Schluter D., Budinger E. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One 2012, 7:e35516.
20. Hettema J.M., Neale M.C., Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 2001, 158:1568-1578.
21. Hinze-Selch D., Daubener W., Eggert L., Erdag S., Stoltenberg R., Wilms S. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull. 2007, 33:782-788.
22. House P.K., Vyas A., Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One 2011, 6:e23277.
23. Jones J.L., Kruszon-Moran D., Sanders-Lewis K., Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am. J. Trop. Med. Hyg. 2007, 77:405-410.
24. Jongert E., Roberts C.W., Gargano N., Forster-Waldl E., Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem. Inst. Oswaldo Cruz 2009, 104:252-266.
25. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
26. Koenen K.C., Amstadter A.B., Ruggiero K.J., Acierno R., Galea S., Kilpatrick D.G., Gelernter J. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress. Anxiety 2009, 26:309-315.
27. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16:606-613.
28. Lafferty K.D. The evolution of trophic transmission. Parasitol. Today 1999, 15:111-115.
29. Miman O., Mutlu E.A., Ozcan O., Atambay M., Karlidag R., Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder?. Psychiatry Res. 2010, 177:263-265.
30. Mitra R., Sapolsky R.M., Vyas A. Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion. Dis. Models & Mechanisms 2013, 6:516-520.
31. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
32. Pearce B.D., Kruszon-Moran D., Jones J.L. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol. Psychiatry 2012, 72:290-295.
33. Prandovszky E., Gaskell E., Martin H., Dubey J.P., Webster J.P., McConkey G.A. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 2011, 6:e23866.
34. Rothman K.J., Greenland S., Lash T.L. Modern Epidemiology 2012, Lippincott Williams & Wilkins, Philadelphia, PA. third ed.
35. Rowe D.C., Stever C., Gard J.M., Cleveland H.H., Sanders M.L., Abramowitz A., Kozol S.T., Mohr J.H., Sherman S.L., Waldman I.D. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav. Genet. 1998, 28:215-225.
36. SAS SAS Statistical Software 2008, SAS Institute, Inc, Cary, NC. Version 9.2.
37. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006, 166:1092-1097.
38. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 2000, 157:1552-1562.
39. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38:642-647.
40. Uddin M., Aiello A.E., Wildman D.E., Koenen K.C., Pawelec G., de Los Santos R., Goldmann E., Galea S. Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9470-9475.
41. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., Sapolsky R.M. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6442-6447.
42. Wang H., Yolken R.H., Hoekstra P.J., Burger H., Klein H.C. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study. Schizophr. Res. 2011, 129:47-51.
43. Weathers F.F.J. Psychometric review of PTSD checklist (PCL-C, PCL-S, PCL-M, PCL-R). Measurement of Stress, Trauma, and Adaptation 1996, Sidran Press, Lutherville, MD. B.H. Stamm (Ed.).
44. Webster J.P. The effect of Toxoplasma gondii and other parasites on activity levels in wild and hybrid Rattus norvegicus. Parasitology 1994, 109(Pt. 5):583-589.
45. Webster J.P. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr. Bull. 2007, 33:752-756.
46. Webster J.P., Brunton C.F., MacDonald D.W. Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology 1994, 109(Pt. 1):37-43.
47. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 2006, 273:1023-1030.
48. Xian H., Chantarujikapong S.I., Scherrer J.F., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M., True W.R. Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug. Alcohol Depend. 2000, 61:95-102.
49. Yolken R.H., Torrey E.F., Lieberman J.A., Yang S., Dickerson F.B. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr. Res. 2011, 128:61-65.